Showing items 101–116
Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1
Grant US-9095552-B2
United States of America
Modified polynucleotides for treating galactosylceramidase protein deficiency
Grant US-9089604-B2
United States of America
Modified polynucleotides for treating protein deficiency
Grant US-9061059-B2
United States of America
Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator
Grant US-9050297-B2
United States of America
Modified polynucleotides for the production of biologics and proteins associated with…
Grant US-8999380-B2
United States of America
Compositions and methods of altering cholesterol levels
Grant US-8980864-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-8822663-B2
United States of America
DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotides
Grant US-8754062-B2
United States of America
Engineered nucleic acids encoding a modified erythropoietin and their expression
Grant US-8710200-B2
United States of America
Modified polynucleotides for the production of G-CSF
Grant US-8680069-B2
United States of America
Method for producing a protein of interest in a primate
Grant US-8664194-B2
United States of America
Engineering and delivery of therapeutic compositions of freshly isolated cells
Application US-8450112-B2
United States of America
ENGINEERING AND DELIVERY OF THERAPEUTIC COMPOSITIONS OF FRESHLY ISOLATED CELLS
Application EP-2279253-A4
European Patent Office
Modification of RNA resulting in improved transcript stability and translation efficiency
Application EP-2357230-A1
European Patent Office
ENGINEERING AND DELIVERY OF THERAPEUTIC COMPOSITIONS OF FRESHLY ISOLATED CELLS
Application EP-2279253-A2
European Patent Office
Showing items 101–116